New 30-year study links inflammation and cholesterol to higher stroke risk in women. Keep reading to find out more.

Ultra-processed foods were linked to higher inflammation and health risks in a study. Learn what the latest research reveals ...

San Diego-based inflammatory diseases specialist Ventyx Biosciences announced positive results from its Phase II study of ...

Ventyx Biosciences Inc. (NASDAQ: VTYX) jumped 86.53% to $7.20 in after-hours trading on Wednesday after the company reported ...

Ventyx Biosciences shares more than doubled in premarket trading Thursday after the clinical-stage biopharmaceutical company reported positive results from a mid-stage study of its VTX3232 drug ...

The San Diego-based biotech has been evaluating the oral NLRP3 inhibitor, dubbed VTX3232, in a phase 2 study of 175 patients ...

Routine screening for inflammation by measuring high-sensitivity C-reactive protein can help identify individuals at elevated ...

Ultra-processed foods are linked to hidden inflammation that can lead to heart disease, cancer, and premature death.

Ventyx Biosciences, Inc. surged after strong Phase 2 results for VTX3232 in obesity. Click for key insights and what VTYX ...

VTX3232 demonstrated significant reductions in cardiovascular risk factors, with additional benefits when combined with semaglutide VTX3232 monotherapy achieved ~80% reduction in hsCRP within the ...

According to a new study, eating too much of a not-particularly-good thing can have big consequences on your body, starting ...

Ventyx Biosciences (VTYX) stock soar as the company announces data from a Phase 2 trial showing the potential of its cardiovascular drug VTX3232. Read more here.